Dova Pharmaceuticals (DOVA) Misses Q3 EPS by 6c

Dova Pharmaceuticals (NASDAQ: DOVA) reported Q3 EPS of ($0.38), $0.06 worse than the analyst estimate of ($0.32).

For earnings history and earnings-related data on Dova Pharmaceuticals (DOVA) click here.

You May Also Be Interested In

• Is the global equity rally broadening? UBS weighs in
• JPMorgan Upgrades East Japan Railway Co (9020:JP) to Overweight
• Deere & Co. (DE) Tops Q3 EPS by 41c, raises guidance